Technegas Recognised in Updated Clinical Guideline
Filed with ASX · · 2 pages · English
Earlier from Cyclopharm
- Insurer Indemnifies Cyclopharm
- Stanford Children's Health to Implement Technegas
- Colombia Approval Marks 67th Country for Technegas
- Cyclopharm Bell Potter Healthcare Conference Presentation
- Legal Proceedings
Later from Cyclopharm
- COPD Study Leveraging Technegas and AI-Driven Lung Analysis
- Trading Halt
- CYC Unaudited Trading Update - Preliminary FY2025 Results
- Cyclopharm Successfully Completes A$14 million Placement
- Cyclopharm Capital Raising Investor Presentation
Follow Cyclopharm into a list and get an email when it puts out news.
Follow Cyclopharm